Figure 25.

Drug selection for the purpose of termination and prevention of sustained VT associated with organic heart disease. *¹In the cases of sustaining hemodynamically unstable tachycardia, the drug should be administered where immediate direct current defibrillation can be performed. *²Alternative drug when no other antiarrhythmic drug is available. *³The drug should be used only for the monomorphic sustained VT. *⁴The drug should be initiate from low dose and gradually increase for sustained VT. VT, ventricular tachycardia.